Cohance Lifesciences Limited (BOM:543064)
India · Delayed Price · Currency is INR 476.80
-1.20 (-0.25%)
At close: Oct 28, 2026
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 182.14 billion as of October 28, 2026. Its market cap has decreased by 44.02% in one year.
Market Cap
182.14B
Enterprise Value
184.11B
Revenue
21.42B
Global Rank
n/a
Country Rank
n/a
PE Ratio
171.45
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 182.14B, an increase of 540,281.13%. That is a compound annual growth rate of 264.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 182.14B | -9.93% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 337.67B |
| Wockhardt | 294.05B |
| Piramal Pharma | 259.43B |
| Cohance Lifesciences | 177.35B |
| Alivus Life Sciences | 154.94B |
| Eris Lifesciences | 153.33B |
| Alembic Pharmaceuticals | 150.65B |
| NATCO Pharma | 141.53B |